title: Humoral immune responses to XMMCO-791-RTA immunotoxin in colorectal cancer patients.
abstract: Monoclonal antibody 791 (XMMCO-791) recognizes a colorectal tumour-associated antigen. Antibody 791-ricin A chain immunotoxin (XMMCO-791-RTA) inhibits growth of human tumour xenografts and it is therefore being evaluated for the treatment of colorectal cancer. One of the problems with therapy with mouse monoclonal antibodies is they stimulate humoral responses in patients. However antigens linked to ricin are cytotoxic for B cells and therefore XMMCO-791-RTA may not be immunogenic. The humoral antibody response to murine monoclonal antibody XMMCO-791 (IgG2b) conjugated to the plant toxin, ricin A chain (RTA), was measured in colorectal cancer patients in a phase I clinical trial. All patients produced strong responses to the XMMCO-791 immunoglobulin and to RTA. The predominant response to the antibody was against the idiotypic determinant although anti-subclass and anti-mouse antibodies were also detected. A component of the anti-idiotypic immunoglobulin response in the colorectal cancer patients was directed against the combining site of XMMCO-791. These antibodies inhibited in-vitro binding of XMMCO-791 to target 791 cells and so may be inhibitors of repeated immunotoxin therapy. Immunotoxins do not abrogate the immune response to mouse immunoglobulin in vivo but instead are highly immunogenic.
authors: Cancer Research Campaign Laboratories, University of Nottingham, UK.
authors: L G
authors: LG
authors: Durrant
authors: V S
authors: VS
authors: Byers
authors: P J
authors: PJ
authors: Scannon
authors: R
authors: R
authors: Rodvien
authors: K
authors: K
authors: Grant
authors: R A
authors: RA
authors: Robins
authors: R A
authors: RA
authors: Marksman
authors: R W
authors: RW
authors: Baldwin
mesh_terms: D000328:Adult; D000368:Aged; D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000096:biosynthesis; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use; D015179:Colorectal Neoplasms / Q000276:immunology* / Q000628:therapy; D004341:Drug Evaluation; D006801:Humans; D007074:Immunoglobulin G / Q000096:biosynthesis; D007075:Immunoglobulin M / Q000096:biosynthesis; D000922:Immunotoxins / Q000276:immunology* / Q000627:therapeutic use; D008875:Middle Aged; D012276:Ricin / Q000276:immunology*
chemical_list: D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D000922:Immunotoxins; D012276:Ricin